Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Rx-360® Announces 2024 Board of Directors 2023-12-27 13:00
Caliway to Present CBL-514 Phase 2 Study Results for Subcutaneous Fat Reduction at IMCAS 2024 2023-12-27 11:49
PharmaBlock Opens HPAPI GMP Facility at Zhejiang Manufacturing Site 2023-12-27 11:37
Innovent and SanegeneBio Enter Strategic Collaboration to Develop siRNA Drug for the Treatment of Hypertension 2023-12-27 08:00
Jemincare Announces 6 Approvals of Clinical Trials for its Innovative Drugs 2023-12-26 17:26
PharmaBlock Obtained ISO 50001 Certification, Advancing Sustainable Development 2023-12-26 11:00
FDA Keynote Speaker in the Spotlight, CAR-T Industry Leaders Gather for Discussion-Join the 2024 GenScript Biotech Global Forum for a New Journey in Cell and Gene Therapy 2023-12-25 10:15
APL-2301, a compound developed by Asieris for the treatment of Acinetobacter baumannii infection, was approved for Phase I clinical trials in Australia 2023-12-24 17:53
GenSci Launches Global Innovation Hub in Shanghai 2023-12-23 15:41
Oncoshot Teams Up with Zhejiang Ablaze Medicine to Drive Data-Powered Drug Development in China 2023-12-22 13:26
Davos Communications Awards - BGI Genomics Inclusive Instagram Strategy Wins Gold Recognition 2023-12-22 08:19
Juniper Therapeutics Acquires Exclusive Rights for SAR Registration for Anti-Viral COVID-19 Drug from Ping An-Shionogi Hong Kong for Singapore 2023-12-22 07:00
TransThera Announces the Global Multicenter Phase 3 Clinical Trial Completed First Patient Dosing in the US Evaluating Tinengotinib in FGFRi Relapsed/Refractory Patients with Cholangiocarcinoma 2023-12-21 21:45
International Clinical Trial Results Released! Responding to the Virus Resurgence, Lianhua Qingwen Capsules Provide New Evidence 2023-12-21 18:06
CStone sells to Servier its exclusive rights to TIBSOVO® in Greater China and Singapore 2023-12-21 17:10
Everest Medicines' Partner Calliditas Therapeutics Announces Nefecon® the Only FDA-approved Treatment for IgA Nephropathy to Significantly Slow Kidney Function Decline 2023-12-21 10:30
BioCity announces the first patient dosed with its anti-TIM-3 mAb BC3402 in Combination with IMFINZI for the Treatment of Advanced Hepatocellular Carcinoma in a Phase Ib/II Trial 2023-12-21 08:26
/DISREGARD RELEASE: YS Biopharma/ 2023-12-21 05:15
CellOrigin announced treatment of the first patient with CAR-M in China and reported the second generation of CAR-M for solid tumors 2023-12-21 01:00
EpiVax Licenses ISPRI Toolkit to Eisai for Preclinical in silico Immunogenicity Screening 2023-12-20 23:45
1 43 44 45 46 47 896